We propose that mechanosensing and PIEZO1 play a previously unrecognized role in β-cell function and systemic glucose metabolism and that this mechanism becomes defective in patients with type-2 diabetes. This evidence concerns the gene PIEZO1 and type 2 diabetes mellitus.